Table 2.
Relationship between serum HULC and pathological parameters of pancreatic cancer (mean ± SD)
| Clinicopathological parameters | n | HULC | t | P value |
| Gender | 0.016 | 0.987 | ||
| Male | 43 | 4.994 ± 1.520 | ||
| Female | 17 | 4.987 ± 1.451 | ||
| Age (yr) | 0.969 | 0.336 | ||
| < 60 | 35 | 4.834 ± 1.498 | ||
| ≥ 60 | 25 | 5.212 ± 1.477 | ||
| Tumor size (cm) | 3.923 | < 0.001b | ||
| < 2 | 29 | 4.293 ± 1.368 | ||
| ≥ 2 | 31 | 5.900 ± 0.988 | ||
| T staging | 5.248 | < 0.001b | ||
| T1/T2 | 38 | 4.354 ± 1.196 | ||
| T3 | 22 | 6.093 ± 1.304 | ||
| N staging | 1.126 | 0.265 | ||
| N0 | 39 | 4.743 ± 1.497 | ||
| N1 | 21 | 5.286 ± 1.281 | ||
| M staging | 5.120 | < 0.001b | ||
| M0 | 32 | 4.221 ± 1.202 | ||
| M1 | 28 | 5.872 ± 1.295 | ||
| Differentiation | 0.829 | 0.411 | ||
| High/medium | 49 | 4.916 ± 1.420 | ||
| Low | 11 | 5.329 ± 1.802 | ||
| Nerve involvement | 0.401 | 0.690 | ||
| No | 55 | 4.971 ± 1.386 | ||
| Yes | 5 | 5.283 ± 2.876 | ||
| Vascular invasion | 3.660 | < 0.001b | ||
| No | 40 | 4.540 ± 1.324 | ||
| Yes | 20 | 5.896 ± 1.412 | ||
| Smoking history | 0.101 | 0.920 | ||
| No | 36 | 4.976 ± 1.405 | ||
| Yes | 24 | 5.016 ± 1.637 | ||
| History of alcoholism | 0.494 | 0.623 | ||
| No | 42 | 4.929 ± 1.64 | ||
| Yes | 18 | 5.138 ± 1.084 |
b
P < 0.01 for between-group comparisons.